Gail Besner
12Patents
5h-index
10Co-inventors
63Inventor score
Filing activity: Jun 15, 1993 → Mar 16, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5811393A | Heparin binding mitogen with homology to epidermal growth factor (EGF) | Human Necessities | 24 | Expired |
| US6191109A | Methods of treating intestinal ischemia using heparin-binding epidermal growth factor | Human Necessities | 15 | Expired |
| US10369176B2 | Probiotic formulations and methods for use | Human Necessities | 8 | Active |
| US6387878B1 | Methods of treating intestinal ischemia using heparin-binding epidermal growth factor | Human Necessities | 6 | Expired |
| US10624934B2 | Prebiotic formulations | Human Necessities | 6 | Active |
| US11497780B2 | Prebiotic formulations | Human Necessities | 5 | Active |
| US8093213B2 | Heparin binding epidermal growth factor (HB-EGF) for use in methods of treating and preventing intestinal injury related to hemorrhagic shock and resuscitation | Human Necessities | 1 | Active |
| US7276479B2 | Methods of treating intestinal ischemia using heparin-binding epidermal growth factor | Human Necessities | 1 | Expired |
| US9060977B2 | Heparin binding epidermal growth factor (HB-EGF) for use in methods of treating and preventing intestinal injury related to hemorrhagic shock and resuscitation | Human Necessities | 1 | Active |
| US6235884A | Heparin binding mitogen with homology to epidermal growth factor (EGF) | Chemistry; Metallurgy | 0 | Expired |
| US11452748B2 | Probiotic formulations and methods for use | Human Necessities | 0 | Active |
| US12383656B2 | Tissue engineered intestine | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.